Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In this trial in 2,301 pregnant women at high risk of preeclampsia, 4.0-5.1 mg/day of supplemental folic acid from 8 to 16 weeks gestation until delivery did not lower risk of preeclampsia or any other adverse outcome when compared to placebo (subjects in the placebo group could take up to 1.1 mg/day of folic acid) (77)
The outcome of this study demonstrated that VC was just as effective as FC, and both treatment groups significantly improved all the measured skin parameters over that of placebo-control values
Are BPC157 capsules approved for human consumption by regulatory agencies
ARTN 637743
N.BesterJ.PretoriusE
PubMed laboratory research record [PMID: 3247829] PubMed record related to this compound for laboratory literature review
US$ 20.00
US$ 27.25
US$ 24.29
US$ 23.44
US$ 22.40
US$ 22.34
US$ 28.12
US$ 23.01
US$ 22.76
US$ 27.40
US$ 22.50
US$ 21.95
US$ 29.23
US$ 24.31
